Symbols / FMS Stock $22.77 +0.13% Fresenius Medical Care AG

Healthcare • Medical Care Facilities • Germany • NYQ
FMS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Ms. Helen Giza
Exch · Country NYQ · Germany
Market Cap 12.44B
Enterprise Value 16.40B
Income 978.37M
Sales 19.63B
FCF (ttm) 1.56B
Book/sh 28.07
Cash/sh 6.23
Employees 109,698
Insider 10d —
IPO Sep 17, 1996
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 42.76%
P/E 11.56
Forward P/E 5.64
PEG 0.76
P/S 0.63
P/B 0.81
P/C —
EV/EBITDA 6.25
EV/Sales 0.84
Quick Ratio 0.85
Current Ratio 1.26
Debt/Eq 75.67
LT Debt/Eq —
EPS (ttm) 1.97
EPS next Y 4.04
EPS Growth 4.20%
Revenue Growth -0.30%
EPS Gr Q/Q 3.89%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-24
ROA 3.62%
ROE 7.93%
ROIC —
Gross Margin 25.62%
Oper. Margin 11.68%
Profit Margin 4.99%
Shs Outstand 546.41M
Shs Float 192.45M
Insider Own 0.00%
Instit Own 8.64%
Short Float —
Short Ratio 3.37
Short Interest 1.71M
52W High 30.46
vs 52W High -25.25%
52W Low 20.95
vs 52W Low 8.69%
Beta 0.85
Impl. Vol. 1.14%
Rel Volume 0.56
Avg Volume 576.08K
Volume 323.94K
Target (mean) $27.49
Tgt Median $25.80
Tgt Low $18.38
Tgt High $38.53
# Analysts 7
Recom Hold
Prev Close $22.74
Price $22.77
Change 0.13%
About

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$27.49
Mean price target
2. Current target
$22.77
Latest analyst target
3. DCF / Fair value
$51.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$22.77
Low
$18.38
High
$38.53
Mean
$27.49

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-09-02 down UBS Neutral → Sell —
2025-05-12 main Truist Securities Hold → Hold $30
2025-01-06 main Truist Securities Hold → Hold $25
2024-10-07 main Truist Securities Hold → Hold $23
2024-07-31 main Truist Securities Hold → Hold $22
2024-05-15 main Truist Securities Hold → Hold $24
2023-11-24 up HSBC Reduce → Hold —
2023-10-11 main Truist Securities Hold → Hold $24
2023-07-13 main Truist Securities Hold → Hold $28
2023-05-10 main Truist Securities Hold → Hold $26
2023-04-13 main Truist Securities — → Hold $24
2023-02-23 main Truist Securities — → Hold $22
2022-06-22 main Truist Securities — → Hold $27
2021-11-23 init HSBC — → Hold —
2021-11-17 main RBC Capital — → Sector Perform $35
2021-11-11 up Jefferies Underperform → Hold —
2020-05-21 main SunTrust Robinson Humphrey — → Buy $48
2020-05-11 main SunTrust Robinson Humphrey — → Buy $46
2020-04-13 main SunTrust Robinson Humphrey — → Buy $42
2020-02-21 up CFRA Hold → Buy $46
News
RSS: Latest FMS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
19,627.60
+1.51%
19,335.91
-0.61%
19,453.62
+0.29%
19,398.02
Operating Revenue
19,627.60
+1.51%
19,335.91
-0.61%
19,453.62
+0.29%
19,398.02
Cost Of Revenue
14,598.67
+0.13%
14,579.26
+0.35%
14,528.61
+0.17%
14,504.33
Reconciled Cost Of Revenue
14,598.67
+0.13%
14,579.26
+0.35%
14,528.61
+0.17%
14,504.33
Gross Profit
5,028.93
+5.72%
4,756.65
-3.42%
4,925.01
+0.64%
4,893.69
Operating Expense
3,202.11
-2.65%
3,289.27
-4.61%
3,448.36
+0.27%
3,438.95
Research And Development
157.97
-13.91%
183.49
-20.90%
231.97
+1.46%
228.62
Selling General And Administration
3,032.73
-3.50%
3,142.82
-1.67%
3,196.34
+0.82%
3,170.37
Selling And Marketing Expense
618.14
-6.40%
660.43
-6.51%
706.40
-11.80%
800.88
General And Administrative Expense
2,414.59
-2.73%
2,482.39
-0.30%
2,489.93
+5.08%
2,369.49
Other Gand A
2,414.59
-2.73%
2,482.39
-0.30%
2,489.93
+5.08%
2,369.49
Other Operating Expenses
11.40
+130.78%
-37.04
-284.69%
20.05
-49.81%
39.96
Total Expenses
17,800.78
-0.38%
17,868.53
-0.60%
17,976.97
+0.19%
17,943.28
Operating Income
1,826.82
+24.50%
1,467.38
-0.63%
1,476.64
+1.51%
1,454.73
Total Operating Income As Reported
1,827.04
+31.22%
1,392.39
+1.68%
1,369.44
-9.41%
1,511.76
EBITDA
3,397.06
+5.95%
3,206.23
-0.11%
3,209.63
-6.09%
3,417.78
Normalized EBITDA
3,578.21
+4.75%
3,416.09
-0.66%
3,438.62
-3.83%
3,575.52
Reconciled Depreciation
1,500.41
-13.88%
1,742.26
-0.55%
1,751.97
-4.70%
1,838.36
EBIT
1,896.65
+29.56%
1,463.97
+0.43%
1,457.65
-7.71%
1,579.42
Total Unusual Items
-181.16
+13.68%
-209.86
+8.35%
-228.99
-45.17%
-157.74
Total Unusual Items Excluding Goodwill
-181.16
+13.68%
-209.86
+8.35%
-228.99
-45.17%
-157.74
Special Income Charges
-60.32
+73.87%
-230.83
-10.89%
-208.16
-1085.38%
-17.56
Net Income
978.37
+81.88%
537.91
+7.80%
499.00
-25.90%
673.40
Pretax Income
1,512.24
+43.08%
1,056.93
+2.31%
1,033.02
-15.28%
1,219.28
Net Non Operating Interest Income Expense
-314.80
+6.16%
-335.47
+0.28%
-336.42
-15.03%
-292.48
Interest Expense Non Operating
384.41
-5.56%
407.04
-4.14%
424.64
+17.91%
360.14
Net Interest Income
-314.80
+6.16%
-335.47
+0.28%
-336.42
-15.03%
-292.48
Interest Expense
384.41
-5.56%
407.04
-4.14%
424.64
+17.91%
360.14
Interest Income Non Operating
69.61
-2.74%
71.58
-18.86%
88.22
+30.38%
67.66
Interest Income
69.61
-2.74%
71.58
-18.86%
88.22
+30.38%
67.66
Other Income Expense
0.21
+100.28%
-74.98
+30.06%
-107.21
-288.01%
57.02
Gain On Sale Of Security
-120.83
-676.19%
20.97
+200.69%
-20.83
+85.14%
-140.18
Gain On Sale Of Business
-61.32
+75.02%
-245.49
-15.25%
-213.00
-229.04%
-64.73
Tax Provision
320.97
+1.56%
316.06
+5.16%
300.56
-7.51%
324.95
Tax Rate For Calcs
0.00
-29.10%
0.00
+2.75%
0.00
+8.99%
0.00
Tax Effect Of Unusual Items
-38.41
+38.79%
-62.75
+5.84%
-66.64
-58.22%
-42.12
Net Income Including Noncontrolling Interests
1,191.27
+60.79%
740.87
+1.15%
732.46
-18.10%
894.33
Net Income From Continuing Operation Net Minority Interest
978.37
+81.88%
537.91
+7.80%
499.00
-25.90%
673.40
Net Income From Continuing And Discontinued Operation
978.37
+81.88%
537.91
+7.80%
499.00
-25.90%
673.40
Net Income Continuous Operations
1,191.27
+60.79%
740.87
+1.15%
732.46
-18.10%
894.33
Minority Interests
-212.90
-4.90%
-202.96
+13.07%
-233.46
-5.68%
-220.92
Normalized Income
1,121.12
+63.66%
685.02
+3.58%
661.35
-16.18%
789.03
Net Income Common Stockholders
978.37
+81.88%
537.91
+7.80%
499.00
-25.90%
673.40
Diluted EPS
1.68
+83.61%
0.92
+7.65%
0.85
-26.09%
1.15
Basic EPS
1.68
+83.61%
0.92
+7.65%
0.85
-26.09%
1.15
Basic Average Shares
582.38
-0.76%
586.83
+0.00%
586.83
+0.06%
586.49
Diluted Average Shares
582.38
-0.76%
586.83
+0.00%
586.83
+0.06%
586.49
Diluted NI Availto Com Stockholders
978.37
+81.88%
537.91
+7.80%
499.00
-25.90%
673.40
Earnings From Equity Interest
181.37
+34.47%
134.88
+10.75%
121.78
-43.29%
214.76
Gain On Sale Of PPE
0.99
-93.22%
14.66
+202.87%
4.84
-89.74%
47.17
Line Item Trend 2025-12-31 2023-12-31
Total Assets
31,002.33
-8.63%
33,929.81
Current Assets
7,898.40
-9.23%
8,701.41
Cash Cash Equivalents And Short Term Investments
1,821.29
+20.35%
1,513.31
Cash And Cash Equivalents
1,582.52
+14.92%
1,377.03
Cash Equivalents
—
324.43
Cash Financial
—
1,079.06
Other Short Term Investments
238.77
+75.20%
136.29
Receivables
3,657.34
-9.93%
4,060.64
Accounts Receivable
3,161.30
-7.86%
3,430.93
Receivables Adjustments Allowances
-207.68
+20.69%
-261.85
Other Receivables
292.88
-18.65%
360.05
Taxes Receivable
290.39
-14.11%
338.09
Accrued Interest Receivable
21.40
+52.84%
14.00
Loans Receivable
0.95
-35.30%
1.47
Inventory
2,140.77
-1.76%
2,179.18
Raw Materials
742.75
-8.65%
813.12
Work In Process
146.88
+10.14%
133.35
Finished Goods
1,251.14
+1.50%
1,232.70
Prepaid Assets
23.32
-63.00%
63.01
Restricted Cash
16.59
-37.30%
26.47
Assets Held For Sale Current
3.60
-99.29%
507.60
Hedging Assets Current
23.68
+27.38%
18.59
Other Current Assets
—
—
Total Non Current Assets
23,103.93
-8.42%
25,228.40
Net PPE
6,499.80
-12.80%
7,454.02
Gross PPE
17,678.42
-1.27%
17,906.17
Accumulated Depreciation
-11,178.63
-6.95%
-10,452.15
Properties
0.00
0.00
Land And Improvements
111.94
+4.76%
106.85
Buildings And Improvements
4,405.93
+2.32%
4,306.22
Machinery Furniture Equipment
5,095.19
-18.18%
6,227.69
Construction In Progress
350.63
-8.70%
384.05
Other Properties
1,127.45
+247.80%
324.17
Leases
6,587.28
+0.46%
6,557.18
Goodwill And Other Intangible Assets
14,825.88
-7.41%
16,012.33
Goodwill
13,571.39
-7.36%
14,650.01
Other Intangible Assets
1,254.49
-7.92%
1,362.33
Investments And Advances
1,323.48
+5.50%
1,254.51
Long Term Equity Investment
663.65
+3.22%
642.93
Non Current Deferred Assets
236.55
-16.70%
283.95
Non Current Deferred Taxes Assets
236.55
-16.70%
283.95
Other Non Current Assets
218.22
-2.39%
223.58
Total Liabilities Net Minority Interest
16,719.52
-12.48%
19,103.27
Current Liabilities
6,245.10
+2.18%
6,111.59
Payables And Accrued Expenses
1,377.95
-6.83%
1,478.92
Payables
1,114.62
-9.24%
1,228.10
Accounts Payable
835.55
-5.60%
885.15
Other Payable
0.24
-97.85%
11.09
Current Accrued Expenses
263.33
+4.99%
250.82
Employee Benefits
679.38
-11.71%
769.51
Pensionand Other Post Retirement Benefit Plans Current
683.81
-4.15%
713.41
Total Tax Payable
278.84
-15.98%
331.86
Income Tax Payable
139.59
-27.01%
191.26
Current Debt And Capital Lease Obligation
2,197.33
+40.71%
1,561.56
Current Debt
1,613.04
+70.76%
944.60
Other Current Borrowings
1,596.19
+227.24%
487.77
Current Capital Lease Obligation
584.29
-5.30%
616.96
Current Deferred Liabilities
114.36
+33.26%
85.82
Current Deferred Revenue
114.36
+33.26%
85.82
Other Current Liabilities
1,440.27
-22.03%
1,847.27
Total Non Current Liabilities Net Minority Interest
10,474.42
-19.38%
12,991.68
Long Term Debt And Capital Lease Obligation
8,598.27
-18.02%
10,488.85
Long Term Debt
5,691.85
-18.22%
6,959.86
Long Term Capital Lease Obligation
2,906.42
-17.64%
3,528.99
Long Term Provisions
173.35
-1.11%
175.30
Non Current Pension And Other Postretirement Benefit Plans
574.81
-13.48%
664.33
Tradeand Other Payables Non Current
108.74
+173.58%
39.75
Non Current Deferred Liabilities
699.28
-8.49%
764.16
Non Current Deferred Revenue
9.76
-29.64%
13.87
Non Current Deferred Taxes Liabilities
689.52
-8.10%
750.29
Other Non Current Liabilities
60.36
-5.03%
63.55
Stockholders Equity
13,309.83
-2.28%
13,620.26
Common Stock Equity
13,309.83
-2.28%
13,620.26
Common Stock
293.41
+0.00%
293.41
Share Issued
293.41
+0.00%
293.41
Ordinary Shares Number
279.29
-4.81%
293.41
Treasury Shares Number
14.12
0.00
Additional Paid In Capital
3,079.37
-8.90%
3,380.33
Retained Earnings
12,207.91
+11.78%
10,921.69
Gains Losses Not Affecting Retained Earnings
-1,684.77
-72.77%
-975.17
Treasury Stock
586.09
—
Minority Interest
972.98
-19.34%
1,206.27
Other Equity Adjustments
-1,684.77
-72.77%
-975.17
Total Equity Gross Minority Interest
14,282.81
-3.67%
14,826.53
Total Capitalization
19,001.68
-7.67%
20,580.12
Working Capital
1,653.30
-36.16%
2,589.82
Invested Capital
20,614.73
-4.23%
21,524.73
Total Debt
10,795.60
-10.41%
12,050.41
Net Debt
5,722.38
-12.33%
6,527.44
Capital Lease Obligations
3,490.71
-15.80%
4,145.95
Net Tangible Assets
-1,516.05
+36.62%
-2,392.07
Tangible Book Value
-1,516.05
+36.62%
-2,392.07
Available For Sale Securities
357.15
+9.06%
327.48
Commercial Paper
—
399.08
Current Provisions
431.37
+1.59%
424.61
Derivative Product Liabilities
155.03
-77.55%
690.57
Duefrom Related Parties Current
32.68
-80.23%
165.30
Held To Maturity Securities
302.68
+6.54%
284.10
Interest Payable
—
—
Investmentin Financial Assets
659.83
+7.89%
611.58
Investments In Other Ventures Under Equity Method
—
754.51
Investmentsin Associatesat Cost
—
41.59
Line Of Credit
16.85
-70.82%
57.75
Notes Receivable
65.42
+416.84%
12.66
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,681.00
+12.36%
2,386.14
-9.23%
2,628.80
+21.29%
2,167.38
Cash Flow From Continuing Operating Activities
2,681.00
+12.36%
2,386.14
-9.23%
2,628.80
+21.29%
2,167.38
Net Income From Continuing Operations
1,191.27
+60.79%
740.87
+1.15%
732.46
-18.10%
894.33
Depreciation Amortization Depletion
1,500.41
-13.88%
1,742.26
-0.55%
1,751.97
-4.70%
1,838.36
Depreciation
1,500.41
-13.88%
1,742.26
-0.55%
1,751.97
-4.70%
1,838.36
Depreciation And Amortization
1,500.41
-13.88%
1,742.26
-0.55%
1,751.97
-4.70%
1,838.36
Other Non Cash Items
314.80
-6.16%
335.47
-0.28%
336.42
+15.03%
292.48
Stock Based Compensation
—
—
—
—
Deferred Tax
-27.21
+62.55%
-72.67
+40.51%
-122.15
-194.54%
-41.47
Deferred Income Tax
-27.21
+62.55%
-72.67
+40.51%
-122.15
-194.54%
-41.47
Operating Gains Losses
-58.13
+60.47%
-147.04
-9.17%
-134.69
+18.78%
-165.83
Gain Loss On Sale Of PPE
123.23
+1112.78%
-12.17
+5.69%
-12.90
+87.00%
-99.27
Change In Working Capital
138.24
-68.89%
444.31
-20.84%
561.28
+538.27%
-128.07
Change In Receivables
-69.06
+6.01%
-73.48
+51.61%
-151.84
-225.27%
-46.68
Changes In Account Receivables
-69.06
+6.01%
-73.48
+51.61%
-151.84
-225.27%
-46.68
Change In Inventory
-248.66
-330.46%
107.90
+921.13%
-13.14
+93.57%
-204.31
Change In Payables And Accrued Expense
249.06
-60.95%
637.86
+9.87%
580.56
+1966.22%
-31.11
Change In Payable
249.06
-60.95%
637.86
+9.87%
580.56
+1966.22%
-31.11
Change In Account Payable
12.45
-92.00%
155.59
+43.43%
108.48
+130.40%
-356.79
Change In Other Current Assets
206.90
+190.76%
-227.97
-256.47%
145.70
-5.41%
154.03
Investing Cash Flow
-722.53
-750.65%
-84.94
+84.39%
-544.23
+25.93%
-734.73
Cash Flow From Continuing Investing Activities
-722.53
-750.65%
-84.94
+84.39%
-544.23
+25.93%
-734.73
Net PPE Purchase And Sale
-898.67
-31.14%
-685.25
-2.51%
-668.46
+2.81%
-687.78
Purchase Of PPE
-915.37
-30.89%
-699.36
-2.16%
-684.60
+5.44%
-723.99
Sale Of PPE
16.70
+18.38%
14.10
-12.61%
16.14
-55.43%
36.20
Capital Expenditure
-915.37
-30.89%
-699.36
-2.16%
-684.60
+5.44%
-723.99
Net Investment Purchase And Sale
-4.02
+36.80%
-6.37
+50.13%
-12.77
+73.38%
-47.97
Purchase Of Investment
-87.52
-7.39%
-81.50
+20.38%
-102.36
+3.10%
-105.64
Sale Of Investment
83.50
+11.13%
75.13
-16.14%
89.59
+55.36%
57.67
Net Business Purchase And Sale
180.17
-70.30%
606.68
+342.84%
137.00
+13226.75%
1.03
Purchase Of Business
-21.97
+4.74%
-23.07
+34.48%
-35.20
+40.47%
-59.13
Financing Cash Flow
-1,403.21
+45.39%
-2,569.30
-38.24%
-1,858.53
-14.91%
-1,617.36
Cash Flow From Continuing Financing Activities
-1,403.21
+45.39%
-2,569.30
-38.24%
-1,858.53
-14.91%
-1,617.36
Net Issuance Payments Of Debt
149.58
+107.85%
-1,905.15
-60.12%
-1,189.79
-6.42%
-1,118.01
Issuance Of Debt
1,779.01
+1115.79%
146.32
-69.72%
483.21
-71.64%
1,704.02
Repayment Of Debt
-1,629.43
+20.57%
-2,051.47
-22.62%
-1,673.01
+40.72%
-2,822.02
Long Term Debt Issuance
1,622.55
+2537.74%
61.51
-85.28%
417.88
-57.66%
986.92
Long Term Debt Payments
-1,488.62
+1.48%
-1,510.97
-5.81%
-1,428.03
+6.04%
-1,519.77
Net Long Term Debt Issuance
133.93
+109.24%
-1,449.46
-43.49%
-1,010.15
-89.58%
-532.85
Short Term Debt Issuance
156.46
+84.48%
84.81
+29.81%
65.34
-90.89%
717.09
Short Term Debt Payments
-140.81
+73.95%
-540.50
-120.63%
-244.97
+81.19%
-1,302.25
Net Short Term Debt Issuance
15.65
+103.43%
-455.69
-153.67%
-179.64
+69.30%
-585.16
Net Common Stock Issuance
-585.28
0.00
0.00
0.00
Common Stock Payments
-585.28
0.00
0.00
0.00
Common Stock Dividend Paid
—
—
—
-395.56
Cash Dividends Paid
-422.51
-21.01%
-349.16
-6.25%
-328.62
+16.92%
-395.56
Repurchase Of Capital Stock
-585.28
0.00
0.00
0.00
Proceeds From Stock Option Exercised
—
0.00
0.00
-100.00%
20.15
Net Other Financing Charges
-544.99
-73.02%
-314.99
+7.39%
-340.11
-174.40%
-123.95
Changes In Cash
555.26
+307.11%
-268.10
-218.60%
226.04
+222.38%
-184.71
Effect Of Exchange Rate Changes
-141.48
-640.03%
26.20
+136.08%
-72.61
-213.47%
-23.16
Beginning Cash Position
1,185.33
-16.95%
1,427.22
+12.05%
1,273.79
-14.03%
1,481.65
End Cash Position
1,599.11
+34.91%
1,185.33
-16.95%
1,427.22
+12.05%
1,273.79
Free Cash Flow
1,765.63
+4.67%
1,686.79
-13.24%
1,944.20
+34.70%
1,443.39
Change In Income Tax Payable
236.61
-50.94%
482.27
+2.16%
472.08
+44.95%
325.68
Change In Tax Payable
236.61
-50.94%
482.27
+2.16%
472.08
+44.95%
325.68
Dividend Received CFO
139.21
+38.29%
100.66
-54.23%
219.95
+131.01%
95.21
Earnings Losses From Equity Investments
-181.37
-34.47%
-134.88
-10.75%
-121.78
-82.97%
-66.56
Interest Paid CFO
-359.98
+5.57%
-381.23
+3.37%
-394.54
-12.51%
-350.68
Interest Received CFO
68.16
+0.08%
68.10
-22.81%
88.22
+30.38%
67.66
Sale Of Business
202.14
-67.90%
629.75
+265.71%
172.20
+186.23%
60.16
Taxes Refund Paid
-225.75
+49.22%
-444.59
-8.40%
-410.13
-22.57%
-334.62
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category